$1.13B
$65 Million
0.01% of portfolio
8,626,683
Q3 2025
Added 0.19%
$2.38B
$26.5 Million
0.01% of portfolio
615,307
Q3 2025
Reduced 45.22%
$521M
$31.6 Million
0.01% of portfolio
7,865,045
Q3 2025
Reduced 9.04%
$4.32B
$56.8 Million
0.01% of portfolio
877,029
Q3 2025
Reduced 4.43%
$2.55B
$34.5 Million
0.01% of portfolio
601,080
Q3 2025
Reduced 17.22%
$5.87B
$56.5 Million
0.01% of portfolio
1,193,709
Q3 2025
Reduced 14.83%
$1.47B
$58.8 Million
0.01% of portfolio
4,951,356
Q3 2025
Reduced 2.77%
$33.4B
$28.9 Million
0.01% of portfolio
3,091,543
Q3 2025
Reduced 26.96%
$1.63B
$48.9 Million
0.01% of portfolio
2,314,063
Q3 2025
Reduced 6.75%
$509M
$29 Million
0.01% of portfolio
2,408,209
Q3 2025
Reduced 0.47%
$742M
$45.3 Million
0.01% of portfolio
2,543,845
Q3 2025
Reduced 0.44%
$35.9M
$75,000
0.0% of portfolio
44,115
Q3 2025
Reduced 37.65%
$322M
$18.3 Million
0.0% of portfolio
4,583,907
Q3 2025
Reduced 3.45%
$403M
$13.7 Million
0.0% of portfolio
311,278
Q3 2025
Added 2.69%
$266M
$2.2 Million
0.0% of portfolio
722,379
Q3 2025
Reduced 13.92%
$719M
$15.4 Million
0.0% of portfolio
1,553,920
Q3 2025
Reduced 24.74%
$245M
$11.1 Million
0.0% of portfolio
1,345,612
Q3 2025
Reduced 10.07%
$688M
$17.1 Million
0.0% of portfolio
883,181
Q3 2025
Reduced 4.42%
$209M
$721,000
0.0% of portfolio
487,750
Q3 2025
Reduced 26.36%
-
$0
0.0% of portfolio
-
Q3 2025
Added 23.82%
$53.2M
$399,000
0.0% of portfolio
214,546
Q2 2025
Reduced 5.94%
$313M
$12.2 Million
0.0% of portfolio
812,871
Q3 2025
Reduced 2.87%
$31.3B
$13.1 Million
0.0% of portfolio
1,182,337
Q3 2025
Added 37.23%
$3.34B
$21.6 Million
0.0% of portfolio
440,446
Q3 2025
Added 411.47%
-
$0
0.0% of portfolio
-
Q3 2025
Added 15.78%
$457M
$149,000
0.0% of portfolio
32,260
Q3 2025
New
$135M
$8.85 Million
0.0% of portfolio
2,748,296
Q3 2025
Added 1.19%
$926M
$7.56 Million
0.0% of portfolio
682,899
Q3 2025
Reduced 0.93%
$100M
$549,000
0.0% of portfolio
339,293
Q3 2025
Reduced 21.86%
Achieve Life Sciences Inc
-
$0
0.0% of portfolio
-
Q3 2025
New
$168M
$312,000
0.0% of portfolio
164,244
Q3 2025
Reduced 20.76%
$127M
$7.12 Million
0.0% of portfolio
172,955
Q3 2025
Reduced 0.89%
$578M
$4.04 Million
0.0% of portfolio
431,037
Q3 2025
Reduced 2.04%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 11.82%
$32.7M
$55,000
0.0% of portfolio
34,923
Q4 2024
Reduced 31.9%
$72.1M
$77,000
0.0% of portfolio
43,524
Q1 2025
Reduced 55.6%
-
$0
0.0% of portfolio
-
Q3 2025
New
$2.01B
$20.7 Million
0.0% of portfolio
1,386,363
Q3 2025
Reduced 0.24%
$26.4M
$42,000
0.0% of portfolio
52,963
Q3 2025
Reduced 7.52%
$579M
$3.96 Million
0.0% of portfolio
131,313
Q3 2025
Reduced 1.45%
-
$0
0.0% of portfolio
-
Q3 2025
Added 27.49%
$145M
$6.48 Million
0.0% of portfolio
856,652
Q3 2025
Added 10.58%
-
$0
0.0% of portfolio
-
Q3 2025
New
Adverum Biotechnologies Inc
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 18.01%
$366M
$6.59 Million
0.0% of portfolio
4,308,757
Q3 2025
Reduced 7.05%
$309M
$9.86 Million
0.0% of portfolio
1,203,996
Q3 2025
Added 12.48%
$126M
$1.19 Million
0.0% of portfolio
60,673
Q2 2025
Added 3.97%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 39.3%
$394M
$1.32 Million
0.0% of portfolio
345,588
Q3 2025
Reduced 4.82%
$238M
$440,000
0.0% of portfolio
427,996
Q3 2025
Reduced 64.15%